Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
US
|
Europe
|
Latin America
|
Asia Pacific
|
World
|
clinica
Regions
French imaging market: a wealth on investment and opportunity, claims one group
08 September 2011
Generous tax incentives to support innovation development,along with the National Investment Policy launched by the government, have created an optimum environment in France that has allowed the medical imaging sector to thrive. That is the view of ...
 
US FDA announces training programmes for device review staff
08 September 2011
The US FDA is introducing two new training programmes to improve the consistency and skill of its medical device unit staff who review pre-market applications. The programmes, designed for reviewers at the FDA’s Center for Devices and Radiological ...
US FDA analysis blames poor quality 510(k) submissions for delays in reviews
28 July 2011
The time it takes for the US Food and Drug Administration to review 510(k) applications for clearing medical devices has increased because of industry's failure to file submissions of an adequate quality, an internal analysis by the FDA has ...
 
French imaging market: a wealth on investment and opportunity, claims one group
08 September 2011
Generous tax incentives to support innovation development,along with the National Investment Policy launched by the government, have created an optimum environment in France that has allowed the medical imaging sector to thrive. That is the view of ...
NICE OKs percutaneous cryotherapy for renal tumours
28 July 2011
The UK’s National Institute for Health and Clinical Excellence (NICE) has approved the use of percutaneous cryotherapy for the treatment of renal tumours. It is one of four techniques appraised in the latest round of NICE’s interventional procedures ...
 
Brazil courts Iraq’s “valuable unexplored medtech market”
08 September 2011
Iraqi government officials are scheduled to hold a “technical meeting” with Brazilian medtech industry representatives next month in Brasilia to discuss potential supply co-operation agreements. So said the Brazilian industry association, ...
Chile cranks up access to key procedures
12 January 2011
Chile has launched a healthcare voucher scheme to ensure that it meets its obligations to provide timely access to certain key medical procedures. The Bono Auge initiative is an extension of the country’s groundbreaking AUGE – “universal access with ...
 
Single application process for trans-Tasman patents planned for early 2013
21 July 2011
The governments of New Zealand and Australia have agreed on a new trans-Tasman plan to implement a single patent application and examination process for both countries that would provide inventors with a faster, cheaper and more streamlined patent ...
Gyros enlists GE to distribute immunoassay to Japan's biopharma market
14 July 2011
Gyros, which specialises in immunoassays to aid the development of drugs and vaccines, is further strengthening its global footprint by making GE Healthcare the sole distributor of its products in Japan. Uppsala, Sweden-based Gyros already had ...
 
Brazil courts Iraq’s “valuable unexplored medtech market”
08 September 2011
Iraqi government officials are scheduled to hold a “technical meeting” with Brazilian medtech industry representatives next month in Brasilia to discuss potential supply co-operation agreements. So said the Brazilian industry association, ...
Boston Scientific takes Promus Element and Taxus Element to India
18 February 2011
Boston Scientific has launched its third-generation drug-eluting stents (DESs), Promus Element and Taxus Element, in India. The devices elute everolimus and paclitaxel, respectively. India is one of the fastest-growing DES markets in the world, ...
 
Successor at Medtronic must choose how to ride out the bumps
23 February 2011
Ashley Yeo

Bill Hawkins’ yet-to-be-appointed successor at Medtronic may be taking over at what is seen as a bad time for the group and the CRM/cardiovascular industry. But the burning question is who will the new chairman and CEO be? The announcement yesterday ...

 
Out of joint: Japan must nurture markets for innovative technologies
23 June 2011
Japan w ants to develop its medtech industry. So how well does it support the technologies in which it already has a stake? If one was look into the field of joint navigation for an answer, they would find that the response is “Not very well”, ...
 Successor at Medtronic must choose how to ride out the bumps...   The feeling’s mutual: Corin, Stryker end US Cormet distribut...
Successor at Medtronic must choose how to ride out the bumps
23 February 2011
Bill Hawkins’ yet-to-be-appointed successor at Medtronic may be taking over at what is seen as a bad time for the group and the CRM/cardiovascular industry. But the burning question is who will the new chairman and CEO be? The announcement yesterday ...
Off-label promotion: how to avoid falling foul of the US FDA
18 February 2011
Off-label use of medical devices happens so often that it has become the standard of care for some disorders. But the FDA's rules on off-label use of devices are labyrinthine – and its edicts on off-label use versus off-label promotion can ...

Going global: medtech innovation amongst Norwegian companies
28 October 2009
Joseph Harvey

Norway has recently topped the United Nations human development index for 2009, making it the most “developed” country in the world. Surely this provides a background for strong medtech innovation? Joseph Harvey travelled to Oslo to meet with a ...

 
Clinica's MedTech Ventures: Issue 36
28 October 2009

I recently visited Norway with senior business reporter Joseph Harvey to uncover some of the hidden medtech gems there. These were not too hard to find, considering that the country's public healthcare system – which is strongly supportive of ...

 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm